These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 748618)

  • 1. IgG.antibody-dependent cell-mediated cytotoxicity against cultured liver cells in patients with chronic active hepatitis.
    Nonomura A; Shintani T; Ohta G
    Jpn J Exp Med; 1978 Oct; 48(5):381-92. PubMed ID: 748618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro studies on IgG-mediated lymphocyte cytotoxicity in chronic active liver disease.
    Kawanishi H
    Gastroenterology; 1977 Sep; 73(3):549-55. PubMed ID: 892355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of lymphocyte cytotoxicity in chronic active hepatitis.
    Kakumu S; Hara T; Gohji H; Sakamoto N
    Clin Exp Immunol; 1978 Jul; 33(1):71-8. PubMed ID: 709913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. K-cell-mediated antibody-dependent cellular cytotoxicity in chronic active liver disease.
    Kawanishi H; MacDermott RP
    Gastroenterology; 1979 Jan; 76(1):151-8. PubMed ID: 361492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro cell-mediated cytotoxicity for autologous liver cells in chronic non-A, non-B hepatitis.
    Mondelli M; Alberti A; Tremolada F; Williams R; Eddleston AL; Realdi G
    Clin Exp Immunol; 1986 Jan; 63(1):147-55. PubMed ID: 3082546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis.
    Vierling JM; Nelson DL; Strober W; Bundy DM; Jones EA
    J Clin Invest; 1977 Nov; 60(5):1116-28. PubMed ID: 332716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-dependent cell-mediated cytotoxicity (ADCC) and cell-mediated cytotoxicity (CMC) to HBsAg-coated target cells in patients with hepatitis B and chronic hepatitis (CAH).
    Warnatz H; Rösch W; Gerlich W; Gutmann W
    Clin Exp Immunol; 1979 Jan; 35(1):133-40. PubMed ID: 371882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis.
    Eggink HF; Houthoff HJ; Huitema S; Gips CH; Poppema S
    Clin Exp Immunol; 1982 Oct; 50(1):17-24. PubMed ID: 6983407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody dependent cellular cytotoxicity (ADCC) in acute hepatitis B and in chronic active hepatitis.
    Bortolotti F; Realdi G; Diodati G; Fattovich G
    Clin Exp Immunol; 1978 Aug; 33(2):211-6. PubMed ID: 719950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-mediated immunity in acute and chronic hepatitis.
    Wands JR; Perrotto JL; Alpert E; Isselbacher KJ
    J Clin Invest; 1975 May; 55(5):921-9. PubMed ID: 1079030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and humoral immune reactions in chronic active liver disease. II. Lymphocyte subsets and viral antigens in liver biopsies of patients with acute and chronic hepatitis B.
    Eggink HF; Houthoff HJ; Huitema S; Wolters G; Poppema S; Gips CH
    Clin Exp Immunol; 1984 Apr; 56(1):121-8. PubMed ID: 6713726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The IgG antibody reactivity of sera from patients with active chronic hepatitis to a crude liver antigen and liver specific protein (LSP): analysis by ELISA and immunoblotting.
    Sundin U; Heigl Z; Sundqvist KG
    Clin Exp Immunol; 1988 Nov; 74(2):276-82. PubMed ID: 3265656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the pathogenesis of chronic inflammatory liver diseases. I. Membrane-fixed IgG on isolated hepatocytes from patients.
    Hopf U; Arnold W; Meyer zum Büschenfelde KH; Förster E; Bolte JP
    Clin Exp Immunol; 1975 Oct; 22(1):1-8. PubMed ID: 765015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to human immunodeficiency virus in human sera induce cell-mediated lysis of human immunodeficiency virus-infected cells.
    Ojo-Amaize EA; Nishanian P; Keith DE; Houghton RL; Heitjan DF; Fahey JL; Giorgi JV
    J Immunol; 1987 Oct; 139(7):2458-63. PubMed ID: 2821115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T and B lymphocytes in patients with chronic active hepatitis (CAH).
    Colombo M; Vernace SJ; Paronetto F
    Clin Exp Immunol; 1977 Oct; 30(1):4-9. PubMed ID: 304778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Anti-Ia reactivity in sera from patients with chronic active hepatitis (CAH)".
    Levrero M; Barnaba V; Paroli M; Valesini G; Franco A; Laghi V; Cauda R; Balsano F
    J Clin Lab Immunol; 1987 Oct; 24(2):63-8. PubMed ID: 2963916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and characterization of antibody to liver cell membrane in sera from patients with chronic active liver diseases.
    Tsuji T; Araki K; Naito K; Inoue J; Nacashima H
    Acta Med Okayama; 1979 Feb; 33(1):61-6. PubMed ID: 220848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of antibody-dependent cellular cytotoxicity by artificial immune complexes and pathological sera.
    Howat JM; Moore M; Hilton AM; Kimber I
    Immunology; 1979 Jun; 37(2):467-75. PubMed ID: 468310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence against antibody-dependent cell-mediated cytotoxicity as a possible mechanism of liver cell injury in cystic fibrosis.
    Mondelli MU
    Boll Ist Sieroter Milan; 1987; 66(1):66-9. PubMed ID: 3620122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte cytotoxicity to cultured rat liver cells in patients with chronic liver diseases.
    Nonomura A; Shintani T; Ohta G
    Tohoku J Exp Med; 1978 Oct; 126(2):159-71. PubMed ID: 715765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.